(R)-(−)-Phenylephrine hydrochloride powder

(R)-(−)-sec-Butylamine 99%

(R)-(−)-α-Methoxy-α-(trifluoromethyl)phenylacetyl chloride derivatization grade (chiral), LiChropur™, ≥99.0%

(R)-1-Phenyl-2-propyn-1-ol ≥99.0% (sum of enantiomers, GC)

(R)-1-Phenylethanol 97%

(R)-1-[(SP)-2-(Di-tert-butylphosphino)ferrocenyl]ethylbis(2-methylphenyl)phosphine 97%

(R)-1-[(SP)-2-(Dicyclohexylphosphino)ferrocenylethyl]diphenylphosphine ≥97%

(R)-1-[(SP)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldi-tert-butylphosphine ≥97%

(R)-1-[(SP)-2-(Diphenylphosphino)ferrocenyl]ethyldi(3,5-xylyl)phosphine ≥97%

(R)-1-[(SP)-2-(Diphenylphosphino)ferrocenyl]ethyldi-tert-butylphosphine ≥97%

(R)-1-[(SP)-2-(Diphenylphosphino)ferrocenyl]ethyldicyclohexylphosphine ≥97%

(R)-1-{(RP)-2-[2-(Diphenylphosphino)phenyl]ferrocenyl}ethylbis[3,5-bis-(trifluoromethyl)phenyl]phosphine ≥97%

(R)-2-hydroxy-4-methylpentanoic acid AldrichCPR

(R)-2-Methylpiperidine 95%

(R)-3,3′-Bis(2,4,6-triisopropylphenyl)-1,1′-binaphthyl-2,2′-diyl hydrogenphosphate ≥97.0% (qNMR)

(R)-3,3′-Bis(9-anthracenyl)-1,1′-binaphthyl-2,2′-diyl hydrogenphosphate 95%

(R)-3,3′-Bis[3,5-bis(trifluoromethyl)phenyl]-1,1′-binaphthyl-2,2′-diyl hydrogenphosphate 95%

(R)-3-(Boc-amino)piperidine 97%

(R)-4-Benzyl-2-oxazolidinone 99%

(R)-4-Benzylthiazolidine-2-thione ≥97.0%

(R)-Amlodipine Pharmaceutical Analytical Impurity (PAI)

(R)-BIDIME ≥97%

(R)-BINAP

(R)-DM-BINAP

(R)-DM-SEGPHOS®

(R)-MG132

(R)-N-[(1R,2R)-2-(3-(3,5-Bis(trifluoromethyl)phenyl)ureido)cyclohexyl]-tert-butyl-sulfinamide 96%

(R)-Naproxen pharmaceutical impurity standard

(R)-Pantetheine ≥95.0% (HPLC)

(R)-Pantoic acid sodium salt ≥95% (GC)

(R)-PFI-2 ≥97% (HPLC)

(R)-SDP

(R)-SEGPHOS® ≥94%

(R)-Timolol European Pharmacopoeia (EP) Reference Standard

(R)-Tol-BINAP

(R)-VANOL 97%

(R)-VAPOL 97%

(R)-ZINC-3573 ≥98% (HPLC)

(R)-α,α-Bis[3,5-bis(trifluoromethyl)phenyl]-2-pyrrolidinemethanol trimethylsilyl ether technical grade

(R,R)-(-)-Pseudoephedrine solution 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

(R,R)-(–)-2,3-Bis(tert-butylmethylphosphino)quinoxaline ≥95%

(R,R)-(−)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine 98%

(R,R)-(−)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II)

(R,R)-(−)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminomanganese(III) chloride

(R,R)-DACH-naphthyl Trost ligand 95%